Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A multi-center, randomized, double-blind, placebo-controlled phase III clinical trial to
evaluate the effect of injectable Neucardin on the heart function in male patients with
NT-proBNP ≤ 1700 pg/ml and female patients with NT-proBNP ≤ 4000 pg/ml, NYHA II-III chronic
systolic heart failure, and to confirm its efficacy and safety.